EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Human‐Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic Cancers

Alexandra M Psihogios iD, Ayah El-Khatib iD, Kevin Matos, Mashfiqui Rabbi, Jenna Rossoff iD, Shira Dinner, Kristy Zeng, Raymundo Picos, Annisa Ahmed, Esha M Patel iD, Linda Fleisher, Stephen P Hunger und 7 weitere

Pediatric Blood & Cancer · 2025

DOI: 10.1002/pbc.31756 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatric Blood & Cancer, 2025. Verfasst von Alexandra M Psihogios und 18 weiteren Autor:innen. Beteiligte Einrichtung: Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. Hauptthemen laut MEDLINE: Medication Adherence, Mobile Applications, Mercaptopurine, Hematologic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIBIB NIH HHS, NIDA NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Acute lymphoblastic leukemia/lymphoma therapy includes a maintenance phase involving daily administration of an oral chemotherapy called 6‐mercaptopurine (6‐MP). Adolescents and young adults (AYAs) exhibit lower 6‐MP adherence than younger patients, which increases their relapse risk. However, effective oral chemotherapy adherence interventions for this AYA population are lacking.

Objective

This study describes the human‐centered design process of co‐creating ADAPTS, an app‐based just‐in‐time adaptive intervention for 6‐MP adherence in AYAs.

Methods

Across three design waves with input from AYAs ( n = 19) and their caregivers ( n = 14), we conducted interviews to co‐develop and refine ADAPTS. Qualitative data were coded using conventional content analysis to identify themes that informed app design.

Results

Four design priorities for an oral chemotherapy adherence digital intervention were identified: (i) personalize messages to the contextual factors that fluctuate and impact adherence, such as symptoms and mood; (ii) enhance the persuasiveness of adherence messages by framing them positively (e.g., a focus on maintaining remission rather than preventing a relapse), and including the perspectives of peers in popular social media formats; (iii) include customizable app features and the ability to track personal adherence progress; and (iv) facilitate dyadic adherence communication between AYAs and their caregivers, who are often involved.

Conclusions

By developing ADAPTS with AYAs and their caregivers, this digital health intervention offers a novel and patient‐centric approach to enhancing adherence. The resulting design priorities and human‐centered design methods employed have generalizable potential for addressing other AYA cancer health behaviors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Medication AdherenceMobile ApplicationsMercaptopurineHematologic NeoplasmsPrecision MedicinePrecursor Cell Lymphoblastic Leukemia-LymphomaHumansAdolescentMaleFemaleYoung AdultAdministration, OralAdultFollow-Up StudiesDigital Health

Stichwörter der Autor:innen

6‐mercaptopurineacute lymphoblastic leukemiaadherenceadolescentmobile healthyoung adult

Substanzen

Mercaptopurine

Autor:innen und Institutionen

  • Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
  • Robert H. Lurie Comprehensive Cancer Center, Northwestern University, Chicago, Illinois, USA.
  • Ann and Robert H. Lurie Children's Hospital, Chicago, Illinois, USA.
  • Optum AI, United Health Group, Minneapolis, Minnesota, USA.
  • Texas A&M College of Arts and Sciences, College Station, Texas, USA.
  • University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA.

ORCID-Profile: Alexandra M Psihogios, Ayah El-Khatib, Jenna Rossoff, Esha M Patel

Förderung

  • NCI NIH HHS
  • NIBIB NIH HHS
  • NIDA NIH HHS

Zitieren

APA

Psihogios, A. M., El-Khatib, A., Matos, K., Rabbi, M., Rossoff, J., Dinner, S., Zeng, K., Picos, R., Ahmed, A., Patel, E. M., Fleisher, L., Hunger, S. P., Pai, A., Laurenceau, J. P., Rini, C., Barakat, L. P., Schwartz, L. A., Murphy, S., & Yanez, B. (2025). Human‐Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic Cancers. Pediatric Blood & Cancer. https://doi.org/10.1002/pbc.31756

Vancouver

Psihogios AM, El-Khatib A, Matos K, Rabbi M, Rossoff J, Dinner S, et al. Human‐Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic Cancers. Pediatric Blood & Cancer. 2025. doi:10.1002/pbc.31756

BibTeX
@article{Psihogios2025,
  author = {Psihogios, Alexandra M and El-Khatib, Ayah and Matos, Kevin and Rabbi, Mashfiqui and Rossoff, Jenna and Dinner, Shira and Zeng, Kristy and Picos, Raymundo and Ahmed, Annisa and Patel, Esha M and Fleisher, Linda and Hunger, Stephen P and Pai, Ahna and Laurenceau, Jean-Philippe and Rini, Christine and Barakat, Lamia P and Schwartz, Lisa A and Murphy, Susan and Yanez, Betina},
  title = {Human‐Centered Design of a Personalized Digital Health Intervention to Improve Oral Chemotherapy Adherence in Adolescents and Young Adults With Hematologic Cancers},
  journal = {Pediatric Blood & Cancer},
  year = {2025},
  doi = {10.1002/pbc.31756}
}
Kostenlos starten →